$heff's $tation of $tocks & $olid DD

[$hylo]

ZGNX..Zogenix (ZGNX +8.1%) moves up after saying the FDA has scheduled two days of hearings February 7-8 after receiving "comments, petitions, and informal inquiries concerning the extent to which opioid drugs should be used in the treatment of pain." Last week A panel of non-FDA medical experts shot down ZGNX's Zohydro, a hydrocodone pill for chronic pain.